Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 12-2014 | 12-2013 | |
| Sales | 0 | 6,562 | 7,090 | 0 | 0 |
| Cost of Goods | N/A | 3,525 | 4,439 | N/A | N/A |
| Gross Profit | N/A | 3,037 | 2,651 | N/A | N/A |
| Operating Expenses | 0 | 16,750 | 21,400 | 0 | 0 |
| Operating Income | N/A | -13,188 | -18,310 | N/A | N/A |
| Other Income | 0 | 84 | -18 | 0 | 0 |
| Pre-tax Income | 0 | -13,104 | -18,328 | 0 | 0 |
| Income Tax | N/A | -424 | -612 | N/A | N/A |
| Net Income Continuous | N/A | -12,680 | -17,716 | N/A | N/A |
| Net Income | $N/A | $-12,680 | $-17,716 | $N/A | $N/A |
| EPS Basic Total Ops | N/A | -388.70 | -542.95 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | -386.72 | -540.31 | N/A | N/A |
| EPS Diluted Total Ops | N/A | -388.70 | -542.95 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | -386.72 | -540.31 | N/A | N/A |
| EBITDA(a) | $N/A | $-12,397 | $-18,310 | $N/A | $N/A |